Virtus Fund Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Virtus Fund Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.22M	Buy	96,767 +66,829	+223%	+$873K	0.01%	273
2017 Q3	$395K	Sell	29,938 -11,829	-28%	-$163K	﹤0.01%	312
2017 Q2	$671K	Sell	41,767 -1,247	-3%	-$18.1K	0.01%	290
2017 Q1	$615K	Sell	43,014 -2,776	-6%	-$38K	0.01%	299
2016 Q4	$586K	Hold	45,790	–	–	0.01%	317
2016 Q3	$609K	Buy	+45,790	New	+$535K	0.01%	307
2014 Q3	–	Sell	-12,175	Closed	-$156K	–	1532
2014 Q2	$156K	Buy	+12,175	New	+$132K	﹤0.01%	1094

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's IRWD Position: Q4 2017 in Review

Virtus Fund Advisers increased its Ironwood Pharmaceuticals (IRWD) stake by 223% in Q4 2017, buying an estimated $873K and bringing the position to 96,767 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #273.

Virtus Fund Advisers first reported a position in IRWD in Q2 2014 and has held it in 7 quarters since. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

Virtus Fund Advisers held 96,767 shares of Ironwood Pharmaceuticals worth $1.22M as of Q4 2017.
Virtus Fund Advisers bought 66,829 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $873K.
Ironwood Pharmaceuticals made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #273 holding.
Virtus Fund Advisers first reported a position in Ironwood Pharmaceuticals in Q2 2014 and has held it in 7 quarters since.
158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.